ABSTRACT. We searched for key genes that could accurately predict bone mineral density. The gene expression profile GSE7429 was downloaded from the Gene Expression Omnibus database, which includes 20 samples, 10 with high and 10 with low bone mineral density. The differentially expressed genes (DEGs) were identified with packages in R language. Further, BLASTX was used to obtain COG function classifications of all the DEGs. The GOTM software was used to find DEGs enriched modules. The functions of genes in the modules was also predicted with the software GENECODIS. Three hundred and three genes were identified as DEGs by comparing high and low bone mineral density samples; the selected genes were mapped to 14 modules collected in PPID. Genes VDR, ESR1, and NRIP1, located in the same module, were significantly enriched in intracellular receptor-mediated signaling biological processes. We conclude that the genes VDR, ESR1, NRIP1 in B cells have a close relationship with bone mineral density. The expression patterns of these genes could be used to determine osteoprotegerin function and for early diagnosis and prevention of low bone mineral density.
INTRODUCTION
Osteoporosis is the most common and serious skeletal disorder among the elderly and postmenopausal women, and it is characterized by reduced bone mineral density (BMD) and bone microarchitecture degeneration, leading to increased fracture risk (Peacock et al., 2002) . The measurement of BMD has been considered for years to be the "gold standard" in osteoporosis diagnosis (Kiel et al., 2007) .
BMD is known to be highly heritable, and an increasing number of genes have been identified to have independent effects on BMD in osteoporosis, including pre-B-cell leukemia homeobox 1 (PBX1) (Cheung et al., 2009) , apolipoprotein E (APOE) (Singh et al., 2010) , Jagged1 (JAG1) (Kung et al., 2010) , TWIST1 gene (Hwang et al., 2010) , TN-FRSF11B (osteoprotegerin) (Vidal et al., 2011) , and SOX6 (Yang et al., 2012) . In addition, in osteoporotic women, femoral neck BMD shows associations with vitamin D receptor gene (VDR), and lumbar spine BMD with osteoprotegerin (OPG) and tumor necrosis factor superfamily member 11 (TNFSF11) (Mencej-Bedrač et al., 2009) . The interaction between genetic variants in the CD40 and CD40L genes has been demonstrated to exert a role in reducing BMD and increases osteoporosis risk in women. Periostin (POSTN), an extracellular matrix protein secreted by osteoblasts and a regulator of osteoblast differentiation and bone formation, also affects susceptibility to low BMD and osteoporosis (Xiao et al., 2012) . Importantly, a study by Duncan et al. (2011) suggests six new genetic associations in or around the genes CLCN7, GALNT3, IBSP, LTBP3, RSPO3, and SOX4. Loss-offunction gene mutation in GALNT3 causes high bone mass.
However, high throughput screening the differentially expressed genes (DEGs) between high and low bone mineral density samples and function analysis of them remain rare. In this study, we aimed to first screen DEGs between high and low bone mineral density samples by using a microarray dataset available from a public database. Furthermore, the underlying molecular mechanisms of these crucial genes were predicted by biological process enrichment analysis.
MATERIAL AND METHODS

Affymetrix microarray data
The GSE7429 dataset was download from the National Center for Biotechnology Information Gene Expression Omnibus data repository (http://www.ncbi. nlm.nih.gov/geo/). This dataset includes 20 samples from unrelated postmenopausal white women, 10 with high and 10 with low bone mineral density [GPL96 record: (HG-U133A) Affymetrix Human Genome U133A Array] (Xiao et al., 2008) . This study was approved by the Institutional Review Board, and all the subjects signed informed consent documents before entering the project. All the study subjects were whites of European origin recruited from the vicinity of Creighton University in Omaha, NE, USA.
Data preprocessing and analysis of DEGs
The limma method (Xiao et al., 2008) was used to identify DEGs in blood B Y. Chen and R.G. Xia cells from different bone mineral density samples. The original expression datasets from all conditions were processed into expression estimates using packages in R language (Troyanskaya et al., 2001; Fujita et al., 2006) . Significance of gene expression differences was tested by the classical t-test, and the P values were adjusted for multiple comparisons using Bayes' theorem (Benjamini and Hochberg, 1995) . Only the genes showing P < 0.01 were selected as DEGs.
Gene function analysis
The sequence alignment of DEGs with the COGs (clusters of orthologous groups of proteins) database was carried out by BLASTX (E value < 1e-05) (Wootton and Federhen, 1993) . Functional annotation and COG functional classification of DEGs were identified from cellular component, molecular function, and biological process. COG functional classification could give intuitive and rational understanding about DEGs function.
DEGs module enrichment analysis
Under normal conditions, genes cannot carry out their function alone but only if they interact with other factors. In this study, module enrichment analysis of DEGs based on the hypergeometric distribution algorithm module was performed using gene ontology tree machine (GOTM) software (adj P < 0.05) (Zhang et al., 2005) .
Biological process enrichment analysis of DEGs
GeneCodis is a web server application for functional analysis of gene lists that integrates different sources of information (GO, KEGGor or SwissProt) and finds modular patterns of interrelated annotations (Nogales-Cadenas et al., 2009 ). The GENECODIS software (adj P < 0.05) was used to analyze the differentially expressed biological process genes (Tabas-Madrid et al., 2012) .
RESULTS
Identifying DEGs
After data preprocessing, gene expression profile data with higher normalization were used for DEGs analysis (Figure 1 ). We identified 303 DEGS that met the threshold (P < 0.01).
Functional classification of DEGs
BLASTX was used to align sequence of 303 DEGs with the COGs database (E value < 1e-05). Functional classification was based on the degree of sequence alignment of DEGS in the Gene Ontology database (Figure 2 ). The function of DEGs included cellular component, molecular function and biological process. 
DEGs module enrichment analysis
GOTM was used to perform module enrichment analysis of DEGs on the basis of the hypergeometric distribution algorithm (adj P < 0.05). A total of 14 major functional enrichment modules were obtained (Table 1) .
Biological process analysis of DEGs
We analyzed the biological process for DEGS in all 14 major functional enrichment modules. The results showed that these genes were mainly involved in 7 biological processes, including the intracellular receptor-mediated signaling pathway, interaction with symbiont, regulation of retinoic acid receptor signaling pathway, polysaccharide transport, retinoic acid receptor signaling pathway, positive regulation of retinoic acid receptor signaling pathway, and lipopolysaccharide transport (Table 2 ). Among them, intracellular receptor-mediated signaling pathway (GO: 0030522) was the most significant biological process, involving the VDR, ESR1 (estrogen receptor 1), and NRIP1 (nuclear receptor interacting protein 1) genes, which formed a module (DB_ID: 900). Further analysis indicated that the expression of VDR and ESR1 were dramatically decreased in blood B cells from low bone mineral density samples. In contrast, the expression of NRIP1 was increased in blood B cells from low bone mineral density samples (Figure 3 ). 
DB_ID
DISCUSSION
Osteoporosis is a common condition of elderly men and women, which manifests clinically by minimal trauma fractures, particularly vertebral and hip fracture (Duncan and Brown, 2008) . From family histories, twin studies, and molecular genetics, it is quite evident now that some of the predisposition for osteoporosis can be inherited. A large number of candidate genes have been identified in one study or another as being associated with osteoporosis. Most genetic studies in osteoporosis to date have focused on the genes of transforming growth factor and growth factors known to be involved in bone turnover (Bertoldo et al., 2000; Ben Amor et al., 2012) , bone component gene (Weichetova et al., 2000) , and hormones and their receptors that are related to bone metabolism (Horner, 2009; Horwitz et al., 2010) . Among these candidate genes, VDR and ESR1 have received more attention (Kung et al., 1998) , which was also the case in our study when comparing the mRNA expression of blood B cells from different bone mineral density samples.
Vitamin D has been demonstrated to be responsible for intestinal calcium absorption and bone metabolism. Vitamin D deficiency can precipitate or exacerbate osteopenia and osteoporosis, cause osteomalacia and muscle weakness, and increase the risk of fracture (Holick, 2007) . Emerging evidence suggests the potential ability of vitamin D exerts important roles in osteoporosis through interaction with its nuclear receptor (VDR ) (Holick and Chen, 2008) . The VDR gene is also significantly associated with bone mineral density [22] . For example, the VDR BBAAtt haplotype has been observed in 23.94% of osteoporosis patients and 5.26% of controls. This haplotype is predicted to be a risk factor for osteoporosis, since an odds ratio (OR) of 5.66 has been found (Zambrano-Morales et al., 2008) . VDR Apa I gene polymorphism is responsible for an important part of the heritable component of lumbar spine BMD in postmenopausal women, possibly related to impaired calcium absorption from the bowel (Dundar et al., 2009) . VDR genotype-dependent increased fracture risk is especially pronounced in interaction with the COLIA1 genotype (Uitterlinden et al., 2001 ).
Endogenous estrogen is quite well known to exert an osteoprotective effect and indeed post-menopausal women with estrogen deficiency suffer osteoporotic defects in bone (Kato, 2009; Khosla, 2010) . Numerous population genetic studies have provided evidence of an association between ESR1 polymorphisms and osteoporotic risk (Liu et al., 2006) . A mutant ESR1 gene has been found to result in reduced BMD in humans (Smith et al., 1994) and mice (Delhon et al., 2009 ). In addition, the ESR1 gene is also positively correlated with the expression of the IGF1 (insulin-like growth factor 1) gene (Mendez et al., 2006) and Runx2 (Khalid et al., 2008) , another important osteogenic growth factor that enhances the function of osteoblasts and prevents osteoblastic apoptosis. In the estrogen receptor signaling pathway, ESR1 positively regulates the activation of MAPK3 (Levin, 2003) , which increases the activation of the nucleus ESR1-estrogen dimer (Likhite et al., 2006) . Downregulation of ESR1 and MAPK3 in B cells controls the secretion of factors, leading to increased osteoclastogenesis or decreased osteoblastogenesis (Xiao et al., 2008) .
NRIP1 (also known as RIP140) is a nuclear protein that specifically interacts with the hormone-dependent activation domain AF2 of nuclear receptors. This protein modulates transcriptional activity of the estrogen receptor (Augereau et al., 2006) . Digenic genotypes involving ESR2-NRIP1 genes are strongly associated with osteoporosis (Morón et al., 2006) .
Although it is controversial whether genetic determinants contribute to osteoporotic fracture, there is no doubt that multiple genes play an important role in the cause of osteoporosis (Albagha and Ralston, 2006) . In this study, 2 lower expression level genes (VDR and ESR1) and 1 higher expression level gene (NRIP1) were identified in B cells of the osteoporosis sample. All these genes play important roles in blocking the decrease in BMD by interacting with their ligands. Our results reveal a new molecular technology for screening those at high-risk for osteoporosis.
